Gastrointestinal cancer incidence in type 2 diabetes mellitus: results from a large population-based cohort study in the UK
Gastrointestinal cancer incidence in type 2 diabetes mellitus: results from a large population-based cohort study in the UK
Background: Patients with type 2 diabetes mellitus (T2DM) have been shown to have higher incidences of liver, pancreatic, and colorectal cancer compared to non-diabetic individuals. Current evidence is conflicting for other gastrointestinal (GI) cancers. Therefore, we aimed to determine incidence rates (IRs) of all GI cancers in patients with and without T2DM. Methods: A cohort study was performed using the UK Clinical Practice Research Datalink (1988-2012). A cohort of antidiabetic drug users was matched at baseline to a non-diabetic cohort, by age, sex, and practice. Crude IRs and 95% confidence intervals (95% CI) of GI cancers per 100,000 person-years were calculated stratified by age, sex, and calendar year. Results: 333,438 T2DM and 333,438 non-diabetic individuals were analyzed. IRs of liver (IR 26, 95% CI 24–28 vs. 8.9, 95% CI 7.7–10), pancreatic (IR 65, 95% CI 62–69 vs. 31, 95% CI 28–34), and colon cancer (IR 119, 95% CI 114–124 vs. 109, 95% CI 104–114) were significantly higher in the diabetic compared to the non-diabetic cohort, whereas the IR of oesophageal cancer was significantly lower (IR 41, 95% CI 39–44 vs. 47, 95% CI 44–51). Sex-specific IRs of colon cancer remained significantly higher in men with T2DM, and IRs of esophageal cancer remained significantly lower in women with T2DM. Conclusion: In this study, T2DM patients were shown to have higher crude IRs of liver, pancreatic and colon cancer, but not of gastric, biliary, and rectal cancer. Moreover, the lower observed IRs of oesophageal cancer in diabetic patients warrants further investigation.
Epidemiology, Gastrointestinal cancer, Incidence, Incidence rates, Type 2 diabetes mellitus
104-111
de Jong, Roy G.P.J.
b4b050d1-3550-4b07-91d3-37d676be6b62
Peeters, Paul J.H.L.
bcd541ac-7a77-4343-ae50-1fb3b07c0873
Burden, Andrea M.
57cecd33-0b9a-4c2d-b3a6-dcbbe648dd75
de Bruin, Marie L.
c5eefcc5-2aa3-4975-aad5-3e4641b7fd02
Haak, Harm R.
250dc392-d8bc-44c6-ac68-9c788b9285c8
Masclee, Ad A.M.
bd19b892-2e34-43ce-a4b8-fbed64cb1fe3
de Vries, Frank
10245a32-6083-4feb-9d20-7e7db0f358b1
Janssen-Heijnen, Maryska L.G.
685edc8f-291c-47c9-ac70-d14d81423cc1
1 June 2018
de Jong, Roy G.P.J.
b4b050d1-3550-4b07-91d3-37d676be6b62
Peeters, Paul J.H.L.
bcd541ac-7a77-4343-ae50-1fb3b07c0873
Burden, Andrea M.
57cecd33-0b9a-4c2d-b3a6-dcbbe648dd75
de Bruin, Marie L.
c5eefcc5-2aa3-4975-aad5-3e4641b7fd02
Haak, Harm R.
250dc392-d8bc-44c6-ac68-9c788b9285c8
Masclee, Ad A.M.
bd19b892-2e34-43ce-a4b8-fbed64cb1fe3
de Vries, Frank
10245a32-6083-4feb-9d20-7e7db0f358b1
Janssen-Heijnen, Maryska L.G.
685edc8f-291c-47c9-ac70-d14d81423cc1
de Jong, Roy G.P.J., Peeters, Paul J.H.L., Burden, Andrea M., de Bruin, Marie L., Haak, Harm R., Masclee, Ad A.M., de Vries, Frank and Janssen-Heijnen, Maryska L.G.
(2018)
Gastrointestinal cancer incidence in type 2 diabetes mellitus: results from a large population-based cohort study in the UK.
Cancer Epidemiology, 54, .
(doi:10.1016/j.canep.2018.04.008).
Abstract
Background: Patients with type 2 diabetes mellitus (T2DM) have been shown to have higher incidences of liver, pancreatic, and colorectal cancer compared to non-diabetic individuals. Current evidence is conflicting for other gastrointestinal (GI) cancers. Therefore, we aimed to determine incidence rates (IRs) of all GI cancers in patients with and without T2DM. Methods: A cohort study was performed using the UK Clinical Practice Research Datalink (1988-2012). A cohort of antidiabetic drug users was matched at baseline to a non-diabetic cohort, by age, sex, and practice. Crude IRs and 95% confidence intervals (95% CI) of GI cancers per 100,000 person-years were calculated stratified by age, sex, and calendar year. Results: 333,438 T2DM and 333,438 non-diabetic individuals were analyzed. IRs of liver (IR 26, 95% CI 24–28 vs. 8.9, 95% CI 7.7–10), pancreatic (IR 65, 95% CI 62–69 vs. 31, 95% CI 28–34), and colon cancer (IR 119, 95% CI 114–124 vs. 109, 95% CI 104–114) were significantly higher in the diabetic compared to the non-diabetic cohort, whereas the IR of oesophageal cancer was significantly lower (IR 41, 95% CI 39–44 vs. 47, 95% CI 44–51). Sex-specific IRs of colon cancer remained significantly higher in men with T2DM, and IRs of esophageal cancer remained significantly lower in women with T2DM. Conclusion: In this study, T2DM patients were shown to have higher crude IRs of liver, pancreatic and colon cancer, but not of gastric, biliary, and rectal cancer. Moreover, the lower observed IRs of oesophageal cancer in diabetic patients warrants further investigation.
This record has no associated files available for download.
More information
Accepted/In Press date: 11 April 2018
e-pub ahead of print date: 16 May 2018
Published date: 1 June 2018
Keywords:
Epidemiology, Gastrointestinal cancer, Incidence, Incidence rates, Type 2 diabetes mellitus
Identifiers
Local EPrints ID: 424881
URI: http://eprints.soton.ac.uk/id/eprint/424881
ISSN: 1877-7821
PURE UUID: dbe28898-4c9a-40e8-8e0f-b2bdc4ec161f
Catalogue record
Date deposited: 05 Oct 2018 11:52
Last modified: 15 Apr 2024 17:06
Export record
Altmetrics
Contributors
Author:
Roy G.P.J. de Jong
Author:
Paul J.H.L. Peeters
Author:
Andrea M. Burden
Author:
Marie L. de Bruin
Author:
Harm R. Haak
Author:
Ad A.M. Masclee
Author:
Frank de Vries
Author:
Maryska L.G. Janssen-Heijnen
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics